For over 120 years, Teva Santé has embodied a clear mission: to improve the quality of life of patients throughout the world. Every day, more than 200 million people benefit from medicines and therapeutic solutions designed to respond to the most common and complex pathologies.
Teva is a key player in the pharmaceutical market, recognized for its expertise in generic, biopharmaceutical and specialty medicines. Present in over 60 countries, the company plays a major role in the distribution of affordable, high-quality treatments, supplying 22,000 pharmacies and 2,300 hospitals and clinics in France. Thanks to its commitment to innovation and research, Teva is constantly enriching its portfolio of medicines, guaranteeing optimal patient care.
Teva's history began in 1901 in Jerusalem as Salomon, Levin and Elstein Ltd, a drug distribution company. In the 1930s, the company took a strategic turn by developing its own pharmaceutical products. In 1976, the merger of the three companies Assia, Zori and Teva gave birth to Teva Pharmaceuticals, a key player in the healthcare sector.
Thanks to a bold acquisition policy, Teva soon became one of the world's leading generics companies. Its portfolio expanded with the acquisition of Copley Pharmaceuticals (1999), Sicor (2004), Ivax Corporation (2006) and Ratiopharm (2010), consolidating its expertise in specialty and injectable therapies.
Today, Teva continues to innovate by investing heavily in biotechnology, neuroscience andimmunology, offering patients ever more appropriate therapeutic solutions.
In France, Teva Santé boasts a broad portfolio of generic and specialty medicines, covering more than 120 pathologies. With over 800 specialties available, the company ranks as the countryᵉ s 4th largest pharmaceutical laboratory in terms of the number of medicines distributed.
Teva Santé's business in France is based on several pillars:
Teva Santé does more than just produce medicines. The company aims to be a responsible player, investing in programs to facilitate access to care and promote the proper use of medicines.
In partnership with theAssociation Bon Usage du Médicament (ABUM), Teva raises awareness among patients and healthcare professionals of good practices in taking medication. The aim is toavoid excessive self-medication, prevent side effects andoptimize the effectiveness of treatments.
Since 2015, Teva has been a partner of the Collectif Je t'Aide, which campaigns for better recognition of family caregivers. The company is developing practical tools and resources to support these people, who are often on the front line of patient care.
Teva Santé integrates an Environmental, Social and Governance (ESG) approach to reduce its carbon footprint, promote respectful production practices and engage in impactful social initiatives.
For over a century, Teva Santé has been committed to the health and well-being of patients. Thanks to its expertise in generic, specialty and biopharmaceutical medicines, the company offers safe, accessible and innovative treatments.
With a strong presence in France and abroad, Teva stands out for its commitment to research, the proper use of medicines and support for caregivers. Far from limiting itself to the production of medicines, the company places people and innovation at the heart of its mission.
Whether it's to relieve pain, treat an infection or improve quality of life, Teva Santé offers an adapted and proven response, guaranteeing confidence and effectiveness for patients and healthcare professionals alike.
